BrainCool AB (publ) update of EU grant (BRAINCELL – combined TTM / thrombectomy treatment)
In April 2020, BrainCool AB received a grant of MEUR 3 with the objective of bringing a combination treatment to market using TTM therapy combined with thrombectomy intervention for stroke patients. The main vision of the project is to bring the product concept, BRAINCELL, the world’s first TTM system that is specifically designed for the needs of stroke patients to the market. BRAINCELL is a system that can cool brain temperatures in a rapid (as soon as stroke is diagnosed), convenient (does not obstruct the head, chest or limb area during thrombectomy treatment)